These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28257284)

  • 21. Rhabdomyolysis and HMG-CoA reductase inhibitors.
    Omar MA; Wilson JP; Cox TS
    Ann Pharmacother; 2001 Sep; 35(9):1096-107. PubMed ID: 11573861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-drug interactions that interfere with statin metabolism.
    Hirota T; Ieiri I
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1435-47. PubMed ID: 26058399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin safety and drug interactions: clinical implications.
    Bottorff MB
    Am J Cardiol; 2006 Apr; 97(8A):27C-31C. PubMed ID: 16581325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin desensitization in a patient with probable familial hypercholesterolemia.
    Schultz AE; Snider MJ; Blais DM; Gulati M
    J Clin Lipidol; 2015; 9(4):597-601. PubMed ID: 26228679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin.
    White CM
    J Clin Pharmacol; 2002 Sep; 42(9):963-70. PubMed ID: 12211221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population.
    Alqasrawi MN; Al-Mahayri ZN; Alblooshi H; Alsafar H; Ali BR
    Curr Vasc Pharmacol; 2024; 22(3):218-229. PubMed ID: 38284696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhabdomyolysis in an elderly multitreated patient: multiple drug interactions after statin withdrawal.
    Ginanneschi F; Volpi N; Giannini F; Rocchi R; Donati D; Aglianò M; Lorenzoni P; Rossi A
    J Neurol Sci; 2014 Jan; 336(1-2):284-7. PubMed ID: 24252882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A missed opportunity for pharmacist involvement.
    Korzec J; Strausbaugh R; Mikolay JJ; Churchwell MD
    J Am Pharm Assoc (2003); 2024; 64(3):102016. PubMed ID: 38272309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosuvastatin and Colchicine combined myotoxicity: lessons to be learnt.
    Sabanis N; Paschou E; Drylli A; Papanikolaou P; Zagkotsis G
    CEN Case Rep; 2021 Nov; 10(4):570-575. PubMed ID: 34028728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the
    Kim CO; Oh ES; Kim H; Park MS
    Drug Des Devel Ther; 2017; 11():503-512. PubMed ID: 28260863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug related colonic perforation: Case report].
    Núñez-García E; Valencia-García LC; Sordo-Mejía R; Kajomovitz-Bialostozky D; Chousleb-Kalach A
    Cir Cir; 2016; 84(1):65-8. PubMed ID: 26242822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ogilvie's syndrome (acute idiopathic colonic pseudo-obstruction) after Caesarean section].
    Ernst RM; Müller RC; Hess T
    Gynakol Geburtshilfliche Rundsch; 2007; 47(4):236-9. PubMed ID: 17914270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case series of 3 patients with acute colonic pseudo-obstruction after vincristine administration.
    Geelen R; Dubois E; Verlinden A; De Schepper H
    Acta Gastroenterol Belg; 2020; 83(4):660-662. PubMed ID: 33321026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.
    García-Rodríguez LA; Massó-González EL; Wallander MA; Johansson S
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):943-52. PubMed ID: 18425988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhabdomyolysis with concurrent atorvastatin and diltiazem.
    Lewin JJ; Nappi JM; Taylor MH
    Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ogilvie's syndrome--acute colonic pseudo-obstruction. Case report and review of the literature.
    Georgescu S; Dubei L; Zaharia M; Cîrdei C; Crumpei F; Cijevschi-Prelipcean C; Stoian M
    Rom J Gastroenterol; 2003 Mar; 12(1):51-5. PubMed ID: 12673381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosuvastatin-related rhabdomyolysis causing severe proximal paraparesis and acute kidney injury.
    Hussain K; Xavier A
    BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31601550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians.
    Kerr KP; Mate KE; Magin PJ; Marley J; Stocks NP; Disler P; Pond CD
    J Clin Pharm Ther; 2014 Aug; 39(4):383-9. PubMed ID: 24702306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin-fluconazole causing rhabdomyolysis.
    Shaukat A; Benekli M; Vladutiu GD; Slack JL; Wetzler M; Baer MR
    Ann Pharmacother; 2003; 37(7-8):1032-5. PubMed ID: 12841814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.